(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Serine phosphorylation of cortactin is required for ECM degradation at invadopodia. (A) A375MM cells transfected with cortactinS405,418D display a remarkably increased ability to degrade the ECM compared with control cells transfected with cortactinWT. By contrast, transfection of cortactinS405,418A markedly reduced ECM degradation. Data represent the mean ± s.d. of three independent experiments. Statistical significance evaluated by Student's t-test: wild type vs S405,418D, P<0.01; wild type vs S405,418A, P<0.005. (B) Representative image of A375MM cells transfected with cortactinS405,418D 48 hours after cortactin depletion. Typically cortactinS405,418D localizes to invadopodia. (C) A375MM cells transfected with the autoinhibitory domain of PAK (AID) display a reduced ability to degrade the matrix compared with mock-transfected cells. Data represent the mean ± s.d. of three independent experiments. Statistical significance was evaluated by Student's t-test: control vs autoinhibitory domain of PAK P<0.0001. (D) A375MM cells were transfected with cortactinWT, nonphosphorylatable cortactinS113A and pseudophosphorylated cortactinS113D. The areas of degradation were then quantified. Data represent the mean ± s.d. of three independent experiments. Statistical significance was evaluated by Student's t-test: wild type vs S113A and S113D, P<0.004. (E) Representative immunofluorescence image of A375MM cells transfected with cortactinS113D 48 hours after cortactin knockdown labeled with anti-FLAG antibodies. CortactinS113D clearly localizes to ECM degradation patches at invadopodia. Scale bars: 10 µm.